CG Oncology Looks Attractive At Current Prices (Rating Upgrade)

Group 1 - CG Oncology, Inc. (NASDAQ: CGON) was previously noted for having promising data but was considered expensive [1] - The stock has decreased by 41% since the last analysis, prompting a reevaluation of the company's prospects [1]